Just before the 23andMe SPAC deal closed, the stock belonging to its merger ... giving investors the impression it is a ...

Me collected information from survey questions about personal health and beyond, such as drinking habits and risk tolerance.

Me is pursuing a sale after filing for bankruptcy, leading many customers to look into deleting their data from the company.

The direct-to-consumer DNA testing service 23andMe filed for bankruptcy earlier this month, putting millions of customers' ...

Competitors like AncestryDNA and MyHeritage, both vying for customers in the at-home genetics and health space ... used by 23andMe, drawn from customer at-home testing kits, poses risks of ...

Me on Sunday filed for bankruptcy in the U.S. after struggling with weak demand for its ancestry testing kits and a 2023 data breach that damaged its reputation.

23andMe bankruptcy underscores the risk of investing in most SPACs. - MarketWatch photo illustration/iStockphoto 23andMe is going bankrupt — underscoring the great ...

Elicit Brewing Co. is expected to open for business in the former Barnes & Noble space in ... also made a $300 million equity investment in 23andMe. When 23andMe went public in 2021, its ...

Just before the 23andMe SPAC deal closed ... giving investors the impression it is a risk-free investment. Some companies do not find appropriate acquisition targets and have to redeem the ...

23andMe is going bankrupt — underscoring the great risks of investing in many of the companies that have gone public via mergers with special-purpose acquisition corporations. When companies opt ...